Empagliflozin reduces diffuse myocardial fibrosis by extracellular volume mapping: A meta-analysis of clinical studies

OBJECTIVE: The aim of the study was to evaluate the effect of empagliflozin on diffuse myocardial fibrosis by cardiac magnetic resonance (CMR) T1 mapping. RESEARCH METHODS AND PROCEDURES: Databases including PubMed, Cochrane library, Embase, and Sinomed for clinical studies of empagliflozin on myoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haipeng, Ding, Lin, Tian, Liwen, Tian, Yutian, Liao, Lin, Zhao, Junyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404239/
https://www.ncbi.nlm.nih.gov/pubmed/36034443
http://dx.doi.org/10.3389/fendo.2022.917761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404239/
https://www.ncbi.nlm.nih.gov/pubmed/36034443
http://dx.doi.org/10.3389/fendo.2022.917761

Ejemplares similares